News

FDA panel to revisit menopausal hormone therapy
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
FDA Commissioner Marty Makary Says The FDA Is 'Now Revising' Saturated Fat Guidelines
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...
BioSpace14h
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
FDA Commissioner Marty Makary Announces Approval Of New Natural Food Dye
'Fridge cigarette' is Gen Z's new Diet Coke obsession that concerns health experts Job No. 1 done, a ‘Trump original’ hangs out her shingle Landlord seeks to evict Republican congressman over unpaid ...
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
FDA commissioner Dr. Marty Makary on vaccine safety and recommendations
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...
Watch CNBC's full interview with FDA commissioner Dr. Marty Makary
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...
STAT8d
Inside the staff exodus and tanking morale that threaten Makary’s FDA
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Hosted on MSN21d
FDA's Makary sought to reject KalVista’s drug: report - MSN
FDA Commissioner Marty Makary reportedly initiated a brief request last week to decline approval of a rare disease drug application from KalVista Pharmaceuticals (NASDAQ: KALV), which is still ...
Wall Street Journal28d
New FDA Chief Marty Makary Wants to Fast-Track Some Drugs, Use More AI ...
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.